Anti-CD22 (SP104) Rabbit Monoclonal Primary Antibody - SFDA Registration ME0000001000SFDAA00188
Access comprehensive regulatory information for Anti-CD22 (SP104) Rabbit Monoclonal Primary Antibody in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000001000SFDAA00188 and manufactured by Ventana Medical Systems, Inc..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Reagent directed against the type 1 integral membrane glycoprotein
Anti-CD22 (SP104) Rabbit Monoclonal Primary Antibody (anti- CD22 (SP104)) is directed against the type 1 integral membrane glycoprotein, CD22. Anti-CD22 (SP104) exhibits a cell membranous and/or cytoplasmic staining pattern and may be used to aid in the identification of B-cell lymphomas. This antibody is intended for qualitative staining of sections of formalin-fixed, paraffin-embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls.
[]